Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
Neurosci Lett
    March 2025
  1. YOKOYAMA K, Mukkatt J, Mathewson N, Fazzolari MD, et al
    Oligomer sensitive in-situ detection and characterization of gold colloid aggregate formations observed within the hippocampus of the Alzheimer's disease rat.
    Neurosci Lett. 2025 Mar 25:138218. doi: 10.1016/j.neulet.2025.138218.
    >> Share

  2. TAHERI S, Paknejadi M, Esmaeili D, Ferdousi A, et al
    Studying the effect of Chlamydia trachomatis, Helicobacter pylori, and Varicella zoster microorganisms in stimulating the expression of cytokines TNFalpha, IFN?, TGFbeta, IL-10 in Alzheimer and non-Alzheimer patients.
    Neurosci Lett. 2025 Mar 9:138192. doi: 10.1016/j.neulet.2025.138192.
    >> Share

  3. ZHANG C, Xu J, Xu F, Xie X, et al
    1-Epilupinine enhances cognition and reduces inflammation in scopolamine-induced dementia model mice.
    Neurosci Lett. 2025;852:138184.
    >> Share

    February 2025
  4. BHAGALOO KA, Yu L, West EA, Chandler DJ, et al
    Alterations in iron levels in the locus coeruleus of a transgenic Alzheimer's disease rat model.
    Neurosci Lett. 2025;850:138151.
    >> Share

  5. MIKKELSEN JD, Linde-Atkins P, Pazarlar BA
    Higher level of [(3)H]UCB-J binding in ApoE E4 allele carriers with Alzheimer disease.
    Neurosci Lett. 2025;849:138135.
    >> Share

    November 2024
  6. HU J, Liu X, Wang J, Yang Q, et al
    Improvement of olfactory function in AD mice mediated by immune responses under 40 Hz light flickering.
    Neurosci Lett. 2024;842:137958.
    >> Share

  7. YANG X, Tohda C
    Diosgenin upregulates axonal guidance partner molecules, Galectin-1 and Secernin-1.
    Neurosci Lett. 2024;842:137954.
    >> Share

    October 2024
  8. STYLA AM, Pitsikas N
    Joint administration of sub-threshold doses of the acetylcholinesterase inhibitor donepezil with those of the NMDA receptor antagonist ketamine improved rats' recognition memory abilities.
    Neurosci Lett. 2024;843:138026.
    >> Share

  9. ANZALONE M, Karam SA, Briting SRR, Petersen S, et al
    Serotonin-2B receptor (5-HT(2B)R) expression and binding in the brain of APP(swe)/PS1(dE9) transgenic mice and in Alzheimer's disease brain tissue.
    Neurosci Lett. 2024 Oct 17:138013. doi: 10.1016/j.neulet.2024.138013.
    >> Share

    September 2024
  10. HOJJATI SH, Butler TA, Luchsinger JA, Benitez R, et al
    Increased between-network connectivity: A risk factor for tau elevation and disease progression.
    Neurosci Lett. 2024;840:137943.
    >> Share

    August 2024
  11. BAGHAEE P, Yoonesi M, Esfahani DE, Beirami E, et al
    Yttrium oxide nanoparticles alleviate cognitive deficits, neuroinflammation, and mitochondrial biogenesis impairment induced by streptozotocin.
    Neurosci Lett. 2024;837:137895.
    >> Share

    July 2024
  12. LOZANO-TOVAR S, Nuccetelli M, Placidi F, Izzi F, et al
    CSF dynamics of orexin and beta-amyloid(42) levels in narcolepsy and Alzheimer's disease patients: A controlled study.
    Neurosci Lett. 2024 Jul 18:137914. doi: 10.1016/j.neulet.2024.137914.
    >> Share

    June 2024
  13. CHITTORA R, Jain S, Roy A, Pandey S, et al
    Multifactorial effects of short duration early exposure low intensity magnetic field stimulation in Streptozotocin induced Alzheimer's disease rat model.
    Neurosci Lett. 2024;836:137878.
    >> Share

  14. SMITH AS, Subramanian J, Doderer J, Moskovitz J, et al
    Methionine oxidation of clusterin in Alzheimer's disease and its effect on clusterin's binding to beta-amyloid.
    Neurosci Lett. 2024;836:137874.
    >> Share

    May 2024
  15. TU Y, Xu B
    Esketamine induces tripartite motif-containing protein 24 to improve cognitive dysfunction in Alzheimer's disease.
    Neurosci Lett. 2024 May 25:137836. doi: 10.1016/j.neulet.2024.137836.
    >> Share

  16. YANG C, Wu X, Feng J, Wu C, et al
    Clinical values of serum C5a in Alzheimer's disease patients with different dementia stages.
    Neurosci Lett. 2024 May 23:137833. doi: 10.1016/j.neulet.2024.137833.
    >> Share

  17. FAZELINEJAD H, Zahedi E, Khadivi M
    Altering plasma lipids and liver enzyme activities via hippocampal injections of hen Lysozyme amyloid aggregates in an Alzheimer's disease mouse model: Insights into the therapeutic role of Bis (Indolyl) phenylmethane.
    Neurosci Lett. 2024;833:137825.
    >> Share

  18. CHEN W, Zhang T, Zhang H
    Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer's disease.
    Neurosci Lett. 2024;832:137816.
    >> Share

  19. AAMERI R, Ghorbani H, Reza Bazrafshan H, Zahra Gharib F, et al
    Retraction notice to "Iranian thyme honey plays behavioral, cellular and molecular important roles as an amazing preventive and therapeutic agent in the brain of Alzheimer's rat model" [Neurosci. Lett. 783 (2022) 136702].
    Neurosci Lett. 2024 May 4:137793. doi: 10.1016/j.neulet.2024.137793.
    >> Share

    April 2024
  20. XIANG X, Xia S, Li S, Zeng Y, et al
    Study on the role and mechanism of Tan IIA in Alzheimer's disease based on CREB-BDNF-TrkB pathway.
    Neurosci Lett. 2024;830:137769.
    >> Share

  21. ZHANG Y, Wu F
    Diagnostic value and cognitive regulatory roles of long non-coding RNA UCA1 in Alzheimer's disease.
    Neurosci Lett. 2024 Apr 5:137765. doi: 10.1016/j.neulet.2024.137765.
    >> Share

    March 2024
  22. CHEN J, Su C, Ma Z, Ou X, et al
    Aerobic exercise suppresses cognitive injury in patients with Alzheimer's disease by regulating long non-coding RNA TUG1.
    Neurosci Lett. 2024;826:137732.
    >> Share

  23. FENG Q, Li X, Liu R, Liu G, et al
    Overexpression of MTMR14 induced learning and memory impairments in 2-month-old C57 mice.
    Neurosci Lett. 2024;825:137700.
    >> Share

    February 2024
  24. SHIGEMATSU K, Komori N, Ideno M, Yamagishi H, et al
    "Evaluation of neprilysin activity in Adipose-Derived stem cells from Alzheimer's disease patients".
    Neurosci Lett. 2024;825:137705.
    >> Share

  25. HUANG W, Chen Q, Zhou P, Ye S, et al
    Neuroprotective effect of chrysophanol in Alzheimer disease via modulating the Ca(2+)/EGFR-PLCgamma pathway.
    Neurosci Lett. 2024 Feb 12:137684. doi: 10.1016/j.neulet.2024.137684.
    >> Share

  26. CAKIR M, Sacmaci H
    The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
    Neurosci Lett. 2024 Feb 11:137683. doi: 10.1016/j.neulet.2024.137683.
    >> Share

  27. KAAR A, Weir MP, Rae MG
    Altered neuronal group 1 metabotropic glutamate receptor- and endoplasmic reticulum-mediated Ca(2+) signaling in two rodent models of Alzheimer's disease.
    Neurosci Lett. 2024;823:137664.
    >> Share

    January 2024
  28. XIE YH, Jiang L, Zhang Y, Deng YH, et al
    Antagonizing LINGO-1 reduces activated microglia and alleviates dendritic spine loss in the hippocampus of APP/PS1 transgenic mice.
    Neurosci Lett. 2024;820:137612.
    >> Share

  29. ROBBIE L, Fernandez SG, Montoya L, Sagare A, et al
    Age of onset predicted by Abeta profiling in a novel PSEN1 (I180F) mutation.
    Neurosci Lett. 2024;820:137591.
    >> Share

  30. CHEN TJ, Hung HS, Cheng TL, Wang DC, et al
    Histone deacetylase inhibitor attenuates the effects of 27-hydroxycholesterol on the rat brain.
    Neurosci Lett. 2024;818:137533.
    >> Share

    December 2023
  31. ZHANG Y, Shen S, Li X, Wang S, et al
    A multiclass extreme gradient boosting model for evaluation of transcriptomic biomarkers in Alzheimer's disease prediction.
    Neurosci Lett. 2023;821:137609.
    >> Share

    November 2023
  32. LIU L, Liu L, Lu Y, Zhang T, et al
    GDP dissociation inhibitor 1 (GDI1) attenuates beta-amyloid-induced neurotoxicity in Alzheimer's diseases.
    Neurosci Lett. 2023;818:137564.
    >> Share

  33. ZARIFKAR AH, Zarifkar A, Safaei S
    Different paradigms of transcranial electrical stimulation induce structural changes in the CA1 region of the hippocampus in a rat model of Alzheimer's disease.
    Neurosci Lett. 2023 Nov 22:137570. doi: 10.1016/j.neulet.2023.137570.
    >> Share

  34. GUO F, Kang J, Xu J, Wei S, et al
    Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in complex diseases of nervous system.
    Neurosci Lett. 2023;817:137513.
    >> Share

  35. ZHANG J, Guo S, Tao R, Wang F, et al
    Neuroprotective effect of plasmalogens on AlCl(3)-induced Alzheimer's disease zebrafish via acting on the regulatory network of ferroptosis, apoptosis and synaptic neurotransmission release with oxidative stress as the center.
    Neurosci Lett. 2023;818:137560.
    >> Share

    October 2023
  36. GHOLAMI A
    Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches.
    Neurosci Lett. 2023;817:137532.
    >> Share

  37. KISHORE N, Goel N
    Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
    Neurosci Lett. 2023 Oct 17:137530. doi: 10.1016/j.neulet.2023.137530.
    >> Share

    September 2023
  38. KAMRANFAR F, Jaktaji RP, Shirani K, Jamshidi A, et al
    Protective effect of a standardized Allium jesdianum extract in an Alzheimer's disease induced rat model.
    Neurosci Lett. 2023 Sep 19:137491. doi: 10.1016/j.neulet.2023.137491.
    >> Share

    August 2023
  39. KARIMI-ZANDI L, Ghorbandaiepour T, Zahmatkesh M
    The increment of annexin V-positive microvesicles versus annexin V-negative microvesicles in CSF of an animal model of Alzheimer's disease.
    Neurosci Lett. 2023;814:137446.
    >> Share

  40. BUDHBHATTI U, Joshi C, Chauhan A, Bhatt D, et al
    Association of NOTCH4 and ACHE gene polymorphism in Alzheimer's disease of Gujarat cohort.
    Neurosci Lett. 2023 Aug 4:137428. doi: 10.1016/j.neulet.2023.137428.
    >> Share

    July 2023
  41. KUO YY, Chen WT, Lin GB, Chen YM, et al
    Thermal cycling-hyperthermia ameliorates Abeta(25-35)-induced cognitive impairment in C57BL/6 mice.
    Neurosci Lett. 2023;810:137337.
    >> Share

  42. ABOLHASANI F, Pourshojaei Y, Mohammadi F, Esmaeilpour K, et al
    Exploring the potential of a novel phenoxyethyl piperidine derivative with cholinesterase inhibitory properties as a treatment for dementia: Insights from STZ animal model of dementia.
    Neurosci Lett. 2023;810:137332.
    >> Share

  43. SHAJI S, Palanisamy R, Swaminathan R
    Structural irregularities in MR corpus callosal images and their association with cerebrospinal fluid biomarkers in Mild Cognitive Impairments.
    Neurosci Lett. 2023;810:137329.
    >> Share

    June 2023
  44. NAKANISHI K, Norimatsu K, Tani A, Matsuoka T, et al
    Effects of early exercise intervention and exercise cessation on neuronal loss and neuroinflammation in a senescence-accelerated mouse prone 8.
    Neurosci Lett. 2023;808:137297.
    >> Share

  45. CHEN L, Wang L, Zhou GF, Liu Y, et al
    TNIP2 inhibits amyloidogenesis by regulating the 3'UTR of BACE1: An in vitro study.
    Neurosci Lett. 2023;808:137265.
    >> Share

  46. WANG M, Zhao H, Zhang Z, Zhao Z, et al
    Down-regulating insulin-like growth factor-1 receptor reduces amyloid-beta deposition in mice cortex induced by chronic sleep restriction.
    Neurosci Lett. 2023;808:137189.
    >> Share

  47. HAMSAFAR Y, Chen Q, Borowsky AD, Beach TG, et al
    Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer's disease.
    Neurosci Lett. 2023 Jun 15:137330. doi: 10.1016/j.neulet.2023.137330.
    >> Share

  48. DELVENNE JF, Scally B, Rose Burke M
    Splenium tract projections of the corpus callosum to the parietal cortex classifies Alzheimer's disease and mild cognitive impairment.
    Neurosci Lett. 2023;810:137331.
    >> Share

    April 2023
  49. DONG L, Chang Q, Ma J, Liu C, et al
    Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Neurosci Lett. 2023;804:137219.
    >> Share

  50. RODRIGUEZ JJ, Terzieva S, Yeh CY, Gardenal E, et al
    Neuroanatomical and morphometric study of S100beta positive astrocytes in the entorhinal cortex during ageing in the 3xTg-Alzehimer's disease mouse model.
    Neurosci Lett. 2023;802:137167.
    >> Share

  51. CAI Y, Fu P, Zhang X
    Association of plasma phosphor-tau181 with Abeta levels may vary by APOE epsilon4 status and sex among non-demented old adults.
    Neurosci Lett. 2023;802:137161.
    >> Share

  52. SOMERA B, Frick M, Fadel JR
    Age-related changes in basal forebrain afferent activation in response to food paired stimuli.
    Neurosci Lett. 2023;802:137155.
    >> Share

    March 2023
  53. XIONG L, Wang Z
    BMP9 ameliorates amyloid pathology by promoting low-density lipoprotein receptor-related protein 1 expression in APP/PS1 transgenic mice.
    Neurosci Lett. 2023;801:137159.
    >> Share

  54. WANG P, Wang X, Qiao K, Zhang Y, et al
    Reduced SUMOylation of Nrf2 signaling contributes to its inhibition induced by amyloid-beta.
    Neurosci Lett. 2023;799:137118.
    >> Share

  55. SINGH L, Singh S
    Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Abeta ((1-42)) and NF-kB expression in experimental model of rats.
    Neurosci Lett. 2023;799:137090.
    >> Share

  56. LI H, Zhang D, Wang X, Wang S, et al
    Protective effect of glutamic-oxaloacetic transaminase on hippocampal neurons in Alzheimer's disease using model mice.
    Neurosci Lett. 2023;803:137194.
    >> Share

  57. WEI R, He JQ, Chen WH, Tam KY, et al
    Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2023 Mar 6:137166. doi: 10.1016/j.neulet.2023.137166.
    >> Share

    February 2023
  58. PEREZ-GARCIA G, Bicak M, Haure-Mirande JV, Perez GM, et al
    BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT(P301S) mouse model of tauopathy.
    Neurosci Lett. 2023;797:137080.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016